Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03091790 · ClinicalTrials.gov registry record · NA
Mesh Type in Ventral Hernia Repair
A NA study of Ventral Hernia, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
- 1
- Study location
NCT03091790: Completed NA study of Ventral Hernia, sponsored by The University of Texas Health Science Center, Houston.
NCT03091790 is a NA study of Ventral Hernia that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 87 participants, below the 138-participant average among 18 other Ventral Hernia trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03091790, a NA study of Ventral Hernia, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
- 1
- Study location
Study Summary
Ventral hernias are common following abdominal surgery. Currently, there is no equipoise on when synthetic and biologic meshes should be used. Among open ventral hernia repairs, half are repaired using biologic mesh while half are repaired using synthetic mesh. The investigators hypothesize that biologic mesh as opposed to synthetic mesh repair of open ventral hernia repair is associated with decreased risk of major complications one year after surgery.
Primary Outcome
Complication defined as hernia recurrence, chronic wound complications including mesh infection, and reoperation
Conditions Studied
Interventions
- DEVICE Synthetic Mesh
- DEVICE Biologic Mesh
Study Locations (1)
Texas
- UT Health at Lyndon B. Johnson General Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2017-03-27 |
| Est. Completion | 2021-07-31 |
| Phase | NA |
What the finished NCT03091790 record still lists
NCT03091790 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, below the 138-participant average among 18 other Ventral Hernia trials with a reported enrollment target (37% lower).
The record links to 1 condition, with Ventral Hernia appearing as the primary indexed condition, and to 2 interventions - of which Synthetic Mesh is the first listed.
NCT03091790 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03091790 about?
NCT03091790 is a clinical study titled "Mesh Type in Ventral Hernia Repair". Ventral hernias are common following abdominal surgery. Currently, there is no equipoise on when synthetic and biologic meshes should be used. Among open ventral hernia repairs, half are repaired using biologic mesh while half are repaired using synthetic mesh. The investigators hypothesize that bio...
What is the current status of trial NCT03091790?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2017-03-27. Estimated completion is 2021-07-31.
What conditions does trial NCT03091790 study?
This clinical trial studies the following conditions: Ventral Hernia.
What interventions are being tested in trial NCT03091790?
The interventions under investigation include: Synthetic Mesh (DEVICE), Biologic Mesh (DEVICE).
Who is sponsoring clinical trial NCT03091790?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03091790 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventral Hernia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03091790's enrollment target sits among peer trials
87 13th of 18 higher than 6 of 18 other Ventral Hernia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ventral Hernia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair
RECRUITING · NA
-
Robotic Versus Open Ventral Hernia Repair
RECRUITING · NA
-
Clinical Investigation of the da Vinci Surgical System
ACTIVE NOT RECRUITING · NA
-
Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Hernia Surgery (Enable Hernia Repair)
ACTIVE NOT RECRUITING · NA
-
Pilot Trial of Abdominal Core Rehabilitation To Improve Outcomes After Ventral Hernia Repair
ACTIVE NOT RECRUITING · NA
-
CYP2D6 Genotype-guided Management of Opioid Analgesics in Patients Undergoing Elective Ventral Hernia Repairs
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI